chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Asthenia, Dizziness, Fatigue, Vertigo
Clinical narrative: Weak; Allergic reaction to an ingredient in the vaccine; tired; Dizziness similar to vertigo; Dizzy/ feeling of room spinning; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy/ feeling of room spinning), ASTHENIA (Weak), VERTIGO (Dizziness similar to vertigo), ALLERGY TO VACCINE (Allergic reaction to an ingredient in the vaccine) and FATIGUE (tired) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 022M20A) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis and Hypersensitivity reaction. Previously administered products included for an unreported indication: SEROQUEL (taken orally). Concurrent medical conditions included Shellfish allergy (Anaphylaxis reaction), Drug allergy (Aspirin- Anaphylaxis reaction) and Asthma. Concomitant products included ALPRAZOLAM (XANAX) for Anxiety, DULOXETINE HYDROCHLORIDE (CYMBALTA) for Depression and Pain, VITAMIN D [VITAMIN D NOS], CALCIUM and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced DIZZINESS (Dizzy/ feeling of room spinning) and VERTIGO (Dizziness similar to vertigo). On 10-Apr-2021, the patient experienced ASTHENIA (Weak), ALLERGY TO VACCINE (Allergic reaction to an ingredient in the vaccine) and FATIGUE (tired). On 23-Apr-2021, DIZZINESS (Dizzy/ feeling of room spinning) and VERTIGO (Dizziness similar to vertigo) had resolved. At the time of the report, ASTHENIA (Weak), ALLERGY TO VACCINE (Allergic reaction to an ingredient in the vaccine) and FATIGUE (tired) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reported that she was prescribed with Meclizine by her health care professional for dizziness but she didn't took it because previously when taken it caused her drowsiness and did not treat her dizziness.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow up received on 2-AUG-2021. Patient demographics, Medical history, 1st dose information, concomitant medications were added : Xanax,calcium and multivitamin, Event outcome reported: Dizziness like vertigo was resolved.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vomiting
Clinical narrative: Vomiting; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting), FATIGUE (fatigue) and HEADACHE (headache) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced VOMITING (Vomiting), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, VOMITING (Vomiting), FATIGUE (fatigue) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Tylenol provided as a Treatment medication.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety
Clinical narrative: Had Anxiety; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Had Anxiety) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No past medical hisory were reported.  Concomitant products included ANXIETY & STRESS for Anxiety, ACETYLSALICYLIC ACID, ASCORBIC ACID (ASPIRIN-C) and ATORVASTATIN for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced ANXIETY (Had Anxiety). At the time of the report, ANXIETY (Had Anxiety) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included acid reflux.  Treatment details not reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Urticaria
Clinical narrative: Started feeling itchy around her waist; Itchy on her arms; It turned into full body being red; Developed hives on upper arms; Later in the evening, she developed hives on upper legs; Red on her entire torso; It was very itchy and red around her neck; Red around neck.; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Started feeling itchy around her waist), PRURITUS (Itchy on her arms), ERYTHEMA (It turned into full body being red), URTICARIA (Developed hives on upper arms) and URTICARIA (Later in the evening, she developed hives on upper legs) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced PRURITUS (Started feeling itchy around her waist), PRURITUS (Itchy on her arms), ERYTHEMA (It turned into full body being red), URTICARIA (Developed hives on upper arms), URTICARIA (Later in the evening, she developed hives on upper legs), ERYTHEMA (Red on her entire torso), PRURITUS (It was very itchy and red around her neck), ERYTHEMA (Red around neck.) and RASH (Rash). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Started feeling itchy around her waist), PRURITUS (Itchy on her arms), ERYTHEMA (It turned into full body being red), URTICARIA (Developed hives on upper arms), URTICARIA (Later in the evening, she developed hives on upper legs), ERYTHEMA (Red on her entire torso), PRURITUS (It was very itchy and red around her neck), ERYTHEMA (Red around neck.) and RASH (Rash) had resolved. Not Provided          No concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Confusional state, Dyspnoea, Feeling abnormal, Gait disturbance
Clinical narrative: Patient has been sick; out of body experiance; has hard time breathing; has metallic taste in his mouth; he can hardly walk; hard time staying awake; his hands bother him; confused; he couldn't think; missed work for few weeks; his legs hurt; He has the side effects of COVID; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Patient has been sick), FEELING ABNORMAL (out of body experiance), DYSPNOEA (has hard time breathing), AGEUSIA (has metallic taste in his mouth) and GAIT DISTURBANCE (he can hardly walk) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced ILLNESS (Patient has been sick), FEELING ABNORMAL (out of body experiance), DYSPNOEA (has hard time breathing), AGEUSIA (has metallic taste in his mouth), GAIT DISTURBANCE (he can hardly walk), HYPERSOMNIA (hard time staying awake), LIMB DISCOMFORT (his hands bother him), CONFUSIONAL STATE (confused), THINKING ABNORMAL (he couldn't think), IMPAIRED WORK ABILITY (missed work for few weeks), PAIN IN EXTREMITY (his legs hurt) and VACCINATION COMPLICATION (He has the side effects of COVID). The patient was treated with PREDNISONE at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, ILLNESS (Patient has been sick), FEELING ABNORMAL (out of body experiance), DYSPNOEA (has hard time breathing), AGEUSIA (has metallic taste in his mouth), GAIT DISTURBANCE (he can hardly walk), HYPERSOMNIA (hard time staying awake), LIMB DISCOMFORT (his hands bother him), CONFUSIONAL STATE (confused), THINKING ABNORMAL (he couldn't think), IMPAIRED WORK ABILITY (missed work for few weeks), PAIN IN EXTREMITY (his legs hurt) and VACCINATION COMPLICATION (He has the side effects of COVID) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  Other treatment medications include inhaler and acid reflux medication.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up received on 26MAY2021, contains non significant information.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersomnia, Illness, Impaired work ability, Limb discomfort, Pain in extremity
Clinical narrative: Patient has been sick; out of body experiance; has hard time breathing; has metallic taste in his mouth; he can hardly walk; hard time staying awake; his hands bother him; confused; he couldn't think; missed work for few weeks; his legs hurt; He has the side effects of COVID; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Patient has been sick), FEELING ABNORMAL (out of body experiance), DYSPNOEA (has hard time breathing), AGEUSIA (has metallic taste in his mouth) and GAIT DISTURBANCE (he can hardly walk) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced ILLNESS (Patient has been sick), FEELING ABNORMAL (out of body experiance), DYSPNOEA (has hard time breathing), AGEUSIA (has metallic taste in his mouth), GAIT DISTURBANCE (he can hardly walk), HYPERSOMNIA (hard time staying awake), LIMB DISCOMFORT (his hands bother him), CONFUSIONAL STATE (confused), THINKING ABNORMAL (he couldn't think), IMPAIRED WORK ABILITY (missed work for few weeks), PAIN IN EXTREMITY (his legs hurt) and VACCINATION COMPLICATION (He has the side effects of COVID). The patient was treated with PREDNISONE at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, ILLNESS (Patient has been sick), FEELING ABNORMAL (out of body experiance), DYSPNOEA (has hard time breathing), AGEUSIA (has metallic taste in his mouth), GAIT DISTURBANCE (he can hardly walk), HYPERSOMNIA (hard time staying awake), LIMB DISCOMFORT (his hands bother him), CONFUSIONAL STATE (confused), THINKING ABNORMAL (he couldn't think), IMPAIRED WORK ABILITY (missed work for few weeks), PAIN IN EXTREMITY (his legs hurt) and VACCINATION COMPLICATION (He has the side effects of COVID) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  Other treatment medications include inhaler and acid reflux medication.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up received on 26MAY2021, contains non significant information.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Thinking abnormal, Vaccination complication
Clinical narrative: Patient has been sick; out of body experiance; has hard time breathing; has metallic taste in his mouth; he can hardly walk; hard time staying awake; his hands bother him; confused; he couldn't think; missed work for few weeks; his legs hurt; He has the side effects of COVID; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Patient has been sick), FEELING ABNORMAL (out of body experiance), DYSPNOEA (has hard time breathing), AGEUSIA (has metallic taste in his mouth) and GAIT DISTURBANCE (he can hardly walk) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced ILLNESS (Patient has been sick), FEELING ABNORMAL (out of body experiance), DYSPNOEA (has hard time breathing), AGEUSIA (has metallic taste in his mouth), GAIT DISTURBANCE (he can hardly walk), HYPERSOMNIA (hard time staying awake), LIMB DISCOMFORT (his hands bother him), CONFUSIONAL STATE (confused), THINKING ABNORMAL (he couldn't think), IMPAIRED WORK ABILITY (missed work for few weeks), PAIN IN EXTREMITY (his legs hurt) and VACCINATION COMPLICATION (He has the side effects of COVID). The patient was treated with PREDNISONE at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, ILLNESS (Patient has been sick), FEELING ABNORMAL (out of body experiance), DYSPNOEA (has hard time breathing), AGEUSIA (has metallic taste in his mouth), GAIT DISTURBANCE (he can hardly walk), HYPERSOMNIA (hard time staying awake), LIMB DISCOMFORT (his hands bother him), CONFUSIONAL STATE (confused), THINKING ABNORMAL (he couldn't think), IMPAIRED WORK ABILITY (missed work for few weeks), PAIN IN EXTREMITY (his legs hurt) and VACCINATION COMPLICATION (He has the side effects of COVID) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  Other treatment medications include inhaler and acid reflux medication.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up received on 26MAY2021, contains non significant information.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Second dose schedualed >36 days after first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose schedualed >36 days after first dose) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J2DA) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 ml. On 19-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose schedualed >36 days after first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose schedualed >36 days after first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Illness, Inappropriate schedule of product administration
Clinical narrative: was unable to get to the appointment due to illness; She did get the second dose last week; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (was unable to get to the appointment due to illness) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She did get the second dose last week) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (was unable to get to the appointment due to illness) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She did get the second dose last week). At the time of the report, ILLNESS (was unable to get to the appointment due to illness) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She did get the second dose last week) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.   This case was linked to MOD-2021-276077, MOD-2021-276077 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow up received-Patient had received second dose hence event (missed dose) was changed to inappropriate schedule of vaccine administration.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vertigo
Clinical narrative: vertigo; similar symptoms to "when I had COVID" after dose 1; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) and VACCINATION COMPLICATION (similar symptoms to "when I had COVID" after dose 1) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (On 14Nov2020 she was hospitalized in ICU step down had double pneumonia. Now has diagnosis of a-fib since being ill with COVID-19.) on 06-Nov-2020. Concomitant products included LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN D 12 HOUR) and DIPHENHYDRAMINE, PARACETAMOL (EXTRA STRENGTH TYLENOL PM) for Allergy.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION COMPLICATION (similar symptoms to "when I had COVID" after dose 1). On 28-Mar-2021, the patient experienced VERTIGO (vertigo). The patient was treated with MECLIZINE [MECLOZINE] on 30-Mar-2021 for Vertigo, at an unspecified dose and frequency. On 30-Mar-2021, VERTIGO (vertigo) had resolved. At the time of the report, VACCINATION COMPLICATION (similar symptoms to "when I had COVID" after dose 1) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-080194 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Follow-up received, updated patient demographics, batch number, de-re-challenge fields, event outcome and added concomitant medications, treatment.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Potential AE due to delay in receiving 2nd dose of Moderna vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Potential AE due to delay in receiving 2nd dose of Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Potential AE due to delay in receiving 2nd dose of Moderna vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Potential AE due to delay in receiving 2nd dose of Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment drugs were reported.   This case was linked to MOD-2021-080280 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Illness, Vaccination complication
Clinical narrative: all "common side effects"; got sick twice; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got sick twice) and VACCINATION COMPLICATION (all "common side effects") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (got sick twice) and VACCINATION COMPLICATION (all "common side effects"). At the time of the report, ILLNESS (got sick twice) and VACCINATION COMPLICATION (all "common side effects") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medication not provided.  Treatment information not provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Depressed mood, Pain in extremity
Clinical narrative: pain in the arm; Feeling down; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (pain in the arm) and DEPRESSED MOOD (Feeling down) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     Concomitant products included ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), MULTIVITAMIN [VITAMINS NOS] and VITAMIN B NOS for an unknown indication.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the arm) and DEPRESSED MOOD (Feeling down). At the time of the report, PAIN IN EXTREMITY (pain in the arm) and DEPRESSED MOOD (Feeling down) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication details were provided.   Reporter did not allow further contact
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Feeling abnormal, Heart rate increased, Insomnia
Clinical narrative: shortness of breath/can't breathe/anxious maybe panic attack; increased heart rate; foggy mind; vertigo (really dizzy); insomnia; can't breathe/anxious maybe panic attack; can't breathe/anxious maybe panic attack; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath/can't breathe/anxious maybe panic attack), HEART RATE INCREASED (increased heart rate), FEELING ABNORMAL (foggy mind), VERTIGO (vertigo (really dizzy)) and INSOMNIA (insomnia) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced DYSPNOEA (shortness of breath/can't breathe/anxious maybe panic attack), HEART RATE INCREASED (increased heart rate), FEELING ABNORMAL (foggy mind), VERTIGO (vertigo (really dizzy)), INSOMNIA (insomnia), DYSPNOEA (can't breathe/anxious maybe panic attack), PANIC ATTACK (can't breathe/anxious maybe panic attack) and CHILLS (chills). On 15-Apr-2021, CHILLS (chills) had resolved. At the time of the report, DYSPNOEA (shortness of breath/can't breathe/anxious maybe panic attack), HEART RATE INCREASED (increased heart rate), FEELING ABNORMAL (foggy mind), VERTIGO (vertigo (really dizzy)), INSOMNIA (insomnia), DYSPNOEA (can't breathe/anxious maybe panic attack) and PANIC ATTACK (can't breathe/anxious maybe panic attack) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Panic attack, Vertigo
Clinical narrative: shortness of breath/can't breathe/anxious maybe panic attack; increased heart rate; foggy mind; vertigo (really dizzy); insomnia; can't breathe/anxious maybe panic attack; can't breathe/anxious maybe panic attack; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath/can't breathe/anxious maybe panic attack), HEART RATE INCREASED (increased heart rate), FEELING ABNORMAL (foggy mind), VERTIGO (vertigo (really dizzy)) and INSOMNIA (insomnia) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced DYSPNOEA (shortness of breath/can't breathe/anxious maybe panic attack), HEART RATE INCREASED (increased heart rate), FEELING ABNORMAL (foggy mind), VERTIGO (vertigo (really dizzy)), INSOMNIA (insomnia), DYSPNOEA (can't breathe/anxious maybe panic attack), PANIC ATTACK (can't breathe/anxious maybe panic attack) and CHILLS (chills). On 15-Apr-2021, CHILLS (chills) had resolved. At the time of the report, DYSPNOEA (shortness of breath/can't breathe/anxious maybe panic attack), HEART RATE INCREASED (increased heart rate), FEELING ABNORMAL (foggy mind), VERTIGO (vertigo (really dizzy)), INSOMNIA (insomnia), DYSPNOEA (can't breathe/anxious maybe panic attack) and PANIC ATTACK (can't breathe/anxious maybe panic attack) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site pain, Yellow skin
Clinical narrative: hands got yellow; strong color and even the fingers are yellow now; feeling down; vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of YELLOW SKIN (hands got yellow), YELLOW SKIN (strong color and even the fingers are yellow now), VACCINATION COMPLICATION (feeling down) and VACCINATION SITE PAIN (vaccination site pain) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 4046b21A) for COVID-19 vaccination.     Concomitant products included ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), MULTI VITAMIN & MINERAL and CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12) for an unknown indication.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced YELLOW SKIN (hands got yellow), YELLOW SKIN (strong color and even the fingers are yellow now), VACCINATION COMPLICATION (feeling down) and VACCINATION SITE PAIN (vaccination site pain). At the time of the report, YELLOW SKIN (hands got yellow), YELLOW SKIN (strong color and even the fingers are yellow now), VACCINATION COMPLICATION (feeling down) and VACCINATION SITE PAIN (vaccination site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Had covid arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Had covid arm) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included APIXABAN (ELIQUIS), DIGOXIN, ISOSORBIDE, LOSARTAN, MAGNESIUM OXIDE, METOPROLOL and SPIRONOLACTONE for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE REACTION (Had covid arm). The patient was treated with TRAMADOL at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (Had covid arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-080282 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080282:1st dose
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Oropharyngeal discomfort, Vision blurred
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of blurred vision, oral hypoesthesia (numb nose and lips) and oropharyngeal discomfort (throat felt heavy) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 031B21A) for COVID-19 immunization. No medical history reported. On Mar 31, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 31, 2021, patient experienced blurred vision, oral hypoesthesia (numb nose and lips) and oropharyngeal discomfort (throat felt heavy). The patient treated with Benadryl (diphenhydramine), paracetamol, phenylpropanolamine hydrochloride; ongoing from Mar 31, 2021, at an unspecified dose and frequency. At the time of the report, blurred vision, oral hypoesthesia (numb nose and lips) and oropharyngeal discomfort (throat felt heavy) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Vaccination site warmth
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site warmth (warm), pruritus (itchy) and rash on arm in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Concurrent medical conditions included a mental impairment. On Apr 5, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 17, 2021, patient experienced vaccination site warmth (warm), pruritus (itchy) and rash on arm. The patient treated with Zyrtec (cetirizine hydrochloride) on Apr 19, 2021; 1 dosage form. At the time of the report, vaccination site warmth (warm), pruritus (itchy) and rash on arm outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant medications not provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Urticaria
Clinical narrative: both arm have a red rash and rash goes from hand to shoulders; both arms have bumps that look like chicken pox and they are dry; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (both arm have a red rash and rash goes from hand to shoulders) and URTICARIA (both arms have bumps that look like chicken pox and they are dry) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042E21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced RASH ERYTHEMATOUS (both arm have a red rash and rash goes from hand to shoulders) and URTICARIA (both arms have bumps that look like chicken pox and they are dry). At the time of the report, RASH ERYTHEMATOUS (both arm have a red rash and rash goes from hand to shoulders) and URTICARIA (both arms have bumps that look like chicken pox and they are dry) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided. No Treatment history was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Headache, Insomnia
Clinical narrative: She felt as if she was wild; She never slept on the same night; An hour & 1/2 later, she started feeling tired after receiving 1st dose; She woke up with chills; Fever; Terrible headache; Muscle aches in her bones at midnight; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (She felt as if she was wild), INSOMNIA (She never slept on the same night), FATIGUE (An hour & 1/2 later, she started feeling tired after receiving 1st dose), CHILLS (She woke up with chills) and PYREXIA (Fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR) and VITAMINS NOS for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 12-Apr-2021, the patient experienced FEELING ABNORMAL (She felt as if she was wild), INSOMNIA (She never slept on the same night), FATIGUE (An hour & 1/2 later, she started feeling tired after receiving 1st dose), CHILLS (She woke up with chills), PYREXIA (Fever), HEADACHE (Terrible headache) and MYALGIA (Muscle aches in her bones at midnight). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (She felt as if she was wild), INSOMNIA (She never slept on the same night), FATIGUE (An hour & 1/2 later, she started feeling tired after receiving 1st dose), CHILLS (She woke up with chills), PYREXIA (Fever), HEADACHE (Terrible headache) and MYALGIA (Muscle aches in her bones at midnight) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Patient was tested Positive with COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional information includes for concomitant product where patient reported of taking Thyroid medication.   This case was linked to MOD-2021-273988 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow up received on 02 Aug 2021, where patient reported of taking second dose of vaccination. No significant information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: She felt as if she was wild; She never slept on the same night; An hour & 1/2 later, she started feeling tired after receiving 1st dose; She woke up with chills; Fever; Terrible headache; Muscle aches in her bones at midnight; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (She felt as if she was wild), INSOMNIA (She never slept on the same night), FATIGUE (An hour & 1/2 later, she started feeling tired after receiving 1st dose), CHILLS (She woke up with chills) and PYREXIA (Fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR) and VITAMINS NOS for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 12-Apr-2021, the patient experienced FEELING ABNORMAL (She felt as if she was wild), INSOMNIA (She never slept on the same night), FATIGUE (An hour & 1/2 later, she started feeling tired after receiving 1st dose), CHILLS (She woke up with chills), PYREXIA (Fever), HEADACHE (Terrible headache) and MYALGIA (Muscle aches in her bones at midnight). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (She felt as if she was wild), INSOMNIA (She never slept on the same night), FATIGUE (An hour & 1/2 later, she started feeling tired after receiving 1st dose), CHILLS (She woke up with chills), PYREXIA (Fever), HEADACHE (Terrible headache) and MYALGIA (Muscle aches in her bones at midnight) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Patient was tested Positive with COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional information includes for concomitant product where patient reported of taking Thyroid medication.   This case was linked to MOD-2021-273988 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow up received on 02 Aug 2021, where patient reported of taking second dose of vaccination. No significant information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Loss of personal independence in daily activities, Neck pain, Peripheral coldness
Clinical narrative: She can't do her normal activities; joint pain in neck; feet are cold; knee pain; cold chills on and off; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Apr-2021 and was forwarded to Moderna on 19-Apr-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (She can't do her normal activities), NECK PAIN (joint pain in neck), PERIPHERAL COLDNESS (feet are cold), ARTHRALGIA (knee pain) and CHILLS (cold chills on and off) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 011L20A) for COVID-19 vaccination.     The patient's past medical history included Meniscus injury (Patient had meniscus -years ago but hadn't been a problem for long time). Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced NECK PAIN (joint pain in neck), PERIPHERAL COLDNESS (feet are cold), ARTHRALGIA (knee pain) and CHILLS (cold chills on and off). On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (She can't do her normal activities). The patient was treated with CORTISONE at a dose of shot. At the time of the report, LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (She can't do her normal activities) and CHILLS (cold chills on and off) outcome was unknown and NECK PAIN (joint pain in neck), PERIPHERAL COLDNESS (feet are cold) and ARTHRALGIA (knee pain) had not resolved.            Patient visited Ortho-surgeon, Endocrinologist and Primary doctor. She went to ER- ran multiple Laboratory tests from Lyme disease to checked for blood clots(all tests came back normal) and blood work(normal).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up Information Received on 07-JUL-2021  contains No New Information.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Lymphadenopathy, Migraine, Nausea
Clinical narrative: Migraine headache; nausea; Lymph nodes in the arms and neck swollen; Tingling in fingers; chills; arm swelled up pretty good; Got sick to her stomach; Slept for 3 hours; Then went to bed that night, slept for 12 hours; slept for 4 or 5 hours; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Got sick to her stomach), SOMNOLENCE (Slept for 3 hours), SOMNOLENCE (Then went to bed that night, slept for 12 hours), SOMNOLENCE (slept for 4 or 5 hours) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 17-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Got sick to her stomach), SOMNOLENCE (Slept for 3 hours), SOMNOLENCE (Then went to bed that night, slept for 12 hours), SOMNOLENCE (slept for 4 or 5 hours) and PERIPHERAL SWELLING (arm swelled up pretty good). On 18-Apr-2021, the patient experienced NAUSEA (nausea), LYMPHADENOPATHY (Lymph nodes in the arms and neck swollen), PARAESTHESIA (Tingling in fingers) and CHILLS (chills). On an unknown date, the patient experienced MIGRAINE (Migraine headache). On 18-Apr-2021, PERIPHERAL SWELLING (arm swelled up pretty good) had resolved. On 19-Apr-2021, ABDOMINAL PAIN UPPER (Got sick to her stomach), SOMNOLENCE (Slept for 3 hours), SOMNOLENCE (Then went to bed that night, slept for 12 hours) and SOMNOLENCE (slept for 4 or 5 hours) had resolved. At the time of the report, NAUSEA (nausea), LYMPHADENOPATHY (Lymph nodes in the arms and neck swollen), PARAESTHESIA (Tingling in fingers), CHILLS (chills) and MIGRAINE (Migraine headache) outcome was unknown.        Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Peripheral swelling, Somnolence
Clinical narrative: Migraine headache; nausea; Lymph nodes in the arms and neck swollen; Tingling in fingers; chills; arm swelled up pretty good; Got sick to her stomach; Slept for 3 hours; Then went to bed that night, slept for 12 hours; slept for 4 or 5 hours; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Got sick to her stomach), SOMNOLENCE (Slept for 3 hours), SOMNOLENCE (Then went to bed that night, slept for 12 hours), SOMNOLENCE (slept for 4 or 5 hours) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 17-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Got sick to her stomach), SOMNOLENCE (Slept for 3 hours), SOMNOLENCE (Then went to bed that night, slept for 12 hours), SOMNOLENCE (slept for 4 or 5 hours) and PERIPHERAL SWELLING (arm swelled up pretty good). On 18-Apr-2021, the patient experienced NAUSEA (nausea), LYMPHADENOPATHY (Lymph nodes in the arms and neck swollen), PARAESTHESIA (Tingling in fingers) and CHILLS (chills). On an unknown date, the patient experienced MIGRAINE (Migraine headache). On 18-Apr-2021, PERIPHERAL SWELLING (arm swelled up pretty good) had resolved. On 19-Apr-2021, ABDOMINAL PAIN UPPER (Got sick to her stomach), SOMNOLENCE (Slept for 3 hours), SOMNOLENCE (Then went to bed that night, slept for 12 hours) and SOMNOLENCE (slept for 4 or 5 hours) had resolved. At the time of the report, NAUSEA (nausea), LYMPHADENOPATHY (Lymph nodes in the arms and neck swollen), PARAESTHESIA (Tingling in fingers), CHILLS (chills) and MIGRAINE (Migraine headache) outcome was unknown.        Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Headache, Malaise, SARS-CoV-1 test
Clinical narrative: COVID-19; Did not feel well; Headache; Tired; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Did not feel well), COVID-19 (COVID-19), HEADACHE (Headache) and FATIGUE (Tired) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     The patient's past medical history included Overweight. Concurrent medical conditions included Hypertension. Concomitant products included LISINOPRIL for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced HEADACHE (Headache) and FATIGUE (Tired). On 05-Apr-2021, the patient experienced MALAISE (Did not feel well). On 06-Apr-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, MALAISE (Did not feel well), HEADACHE (Headache) and FATIGUE (Tired) outcome was unknown and COVID-19 (COVID-19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, SARS-CoV-1 test: positive (Positive) positive.. On an unknown date, SARS-CoV-1 test: negative (Negative) negative..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: body ache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache), CHILLS (chills) and PYREXIA (fever) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 001B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history reported).   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 02-Apr-2021, the patient experienced CHILLS (chills) and PYREXIA (fever). On an unknown date, the patient experienced PAIN (body ache). On 03-Apr-2021, PAIN (body ache), CHILLS (chills) and PYREXIA (fever) outcome was unknown.            no treatment information provided no concomitant medication provided